Gram-positive bacterial cell membrane proteins and enzymes

Gram-positive bacterial cell membrane proteins and enzymes represent a broad class of essential molecular targets located within the cytoplasmic membrane and the thick peptidoglycan layer of Gram-positive bacteria. This group includes Penicillin-Binding Proteins (PBPs), which are critical for cell wall biosynthesis, as well as various transporters and enzymes like MraY and MurG that facilitate the assembly of the bacterial envelope (StatPearls, 2023). Because Gram-positive organisms lack an outer membrane, these membrane-associated proteins are highly accessible to therapeutic agents, making them primary targets for many classes of antibiotics (PubMed, 2021). Drugs such as beta-lactams and glycopeptides exert their bactericidal effects by inhibiting these enzymes or their substrates, leading to impaired structural integrity and eventual cell lysis (NIH, 2022). These targets are vital for maintaining osmotic stability and metabolic functions, and their inhibition is a cornerstone in treating infections caused by pathogens like Staphylococcus aureus and Streptococcus pneumoniae (PubChem, 2023). However, the clinical utility of drugs hitting these targets is frequently challenged by the development of resistance mechanisms, including target site mutations and the upregulation of efflux pumps (Wikipedia, 2024).

Other names

Gram-positive membrane-associated targetsBacterial cytoplasmic membrane proteinsCell wall synthesis enzymesPenicillin-binding proteins (PBPs)Murein biosynthesis enzymes

Inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins (PBPs); disruption of membrane potential and ion leakage; inhibition of lipid carrier (bactoprenol) dephosphorylation; and interference with early-stage murein precursor assembly.